Latest news
VERA Stock Surges After Drug To Treat Rare Kidney Disease Gets FDA Approval – Retail Sees The Move As Catalyst For Vera Therapeutics - StocktwitsStocktwits · Fri, 07 Aug 2026 09:09:07 GMTGalibra Neuroscience Receives FDA Orphan Drug and Rare Pediatric Disease Designations for SSADH Deficiency Gene Therapy - BioSpaceBioSpace · Thu, 06 Aug 2026 04:29:54 GMTTonix Gets FDA Alignment on TNX-4800 Phase 2 Lyme Disease Study Design - The Clinical Trial VanguardThe Clinical Trial Vanguard · Wed, 05 Aug 2026 06:33:35 GMTAspen Neuroscience Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Sasineprocel (ANPD001) to Treat Parkinson's Disease - PR NewswirePR Newswire · Thu, 30 Jul 2026 07:00:00 GMT